GSK Stock: Price, Earnings History and SEC Filings
GSK plc (GSK) last traded at $49.51, up 1.71% on the latest session and up 2.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.47 against an analyst estimate of $1.40, a beat of 5.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GSK earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.47 | $1.40 | +5.00% |
| Jun 2026 | Jul 28, 2026 | $1.36 | $1.27 | +7.09% |
| Mar 2026 | Apr 29, 2026 | $1.24 | $1.17 | +5.98% |
| Dec 2025 | Feb 4, 2026 | $0.68 | $0.64 | +6.25% |
GSK beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GSK
Insider filing activity
GSK insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GSK news
- GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology CaseNov 1, 2026 · finance.yahoo.com
- GSK PlcOct 30, 2026 · 247wallst.com
- GSK: The Gas Pedal Is Still Down, But Bumps AheadOct 29, 2026 · seekingalpha.com
- GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Oct 29, 2026 · finance.yahoo.com
- Chiesi Group appoints Paolo Paoletti to its Board of DirectorsOct 29, 2026 · finance.yahoo.com
- GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention?Oct 29, 2026 · finance.yahoo.com
- Genmab Stock Surges to Record High After Stunning Cancer Drug ResultsOct 28, 2026 · finance.yahoo.com
- Glaxo: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
About GSK plc
GSK plc (GSK) is a US-listed public company on NYSE. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in United Kingdom.